Clinical inertia as a clinical safeguard

JAMA. 2011 Apr 20;305(15):1591-2. doi: 10.1001/jama.2011.490.
No abstract available

MeSH terms

  • Decision Making*
  • Diabetes Mellitus / blood
  • Diabetes Mellitus / drug therapy*
  • Diffusion of Innovation
  • Dyslipidemias / drug therapy*
  • Glycated Hemoglobin A / analysis
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
  • Hypertension / drug therapy*
  • Patient Care / standards*
  • Practice Guidelines as Topic

Substances

  • Glycated Hemoglobin A
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • hemoglobin A1c protein, human